Impact of hepatitis C virus genotype 3 on liver disease progression in a Chinese national cohort-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Impact of hepatitis C virus genotype 3 on liver disease progression in a Chinese national cohort

Published:2020-01-13 Issue:3 Volume:133 Page:253-261
ISSN:0366-6999
Container-title:Chinese Medical Journal
language:en
Short-container-title:

Author:

Wu Nan,Rao Hui-Ying,Yang Wei-Bo,Gao Zhi-Liang,Yang Rui-Feng,Fei Ran,Gao Ying-Hui,Jin Qian,Wei Lai

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine,General Medicine

Reference30 articles.

1. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study;Lancet Gastroenterol Hepatol,2017

2. Hepatitis C virus infection;Manns;Nat Rev Dis Primers,2017

3. Hepatitis C: global epidemiology and strategies for control;Lanini;Clin Microbiol Infect,2016

4. Current challenges and the management of chronic hepatitis C in mainland China;Duan;J Clin Gastroenterol,2014

5. Review article: HCV genotype 3 - the new treatment challenge;Ampuero;Aliment Pharmacol Ther,2014

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk factors for hepatocellular carcinoma associated with hepatitis C genotype 3 infection: A systematic review;World Journal of Gastrointestinal Oncology;2024-04-15

2. Retreatment of patients with chronic hepatitis C, subtype 3a, and cirrhosis, who previously failed a regimen containing second-generation NS5A inhibitors with sofosbuvir + glecaprevir/pibrentasvir and ribavirin for 16-24 weeks;2024-04-10

3. Decreased Efficacy of Sofosbuvir/Velpatasvir in HIV Patients Coinfected with HCV Genotype 3b;Future Virology;2024-01

4. Alfosbuvir plus Daclatasvir for Treatment of Chronic Hepatitis C Virus Infection in China;Infectious Diseases and Therapy;2023-10-19

5. Retreatment of patients with chronic hepatitis C, subtype 3a, and cirrhosis, who previously failed a regimen containing NS5A inhibitors with sofosbuvir/velpatasvir plus ribavirin for 24 weeks;Journal of Clinical Virology Plus;2023-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3